Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
21 Leser
Artikel bewerten:
(0)

Mindray Medical International Honors Altera with Best Quality Award for Delivering Industry-leading FPGA Technology, Service and Support

SAN JOSE, Calif., May 28, 2014 /PRNewswire/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, has awarded Altera Corporation (NASDAQ: ALTR) the 2013 Best Quality Award. From its manufacturing and engineering base in China, Mindray's worldwide distribution network supplies a broad range of products across three primary business segments: patient monitoring and life support, in-vitro diagnostics, and medical imaging systems. Mindray is recognizing Altera for delivering cost-effective, state-of-the-art programmable logic solutions in a timely manner, while consistently meeting high quality, reliability, and service requirements.

Altera(R) programmable solutions enable designers of electronic systems to rapidly and cost effectively innovate, differentiate and win in their markets. Altera offers FPGAs, SoCs, CPLDs, ASICs and complementary technologies, such as power management, to provide high-value solutions to customers worldwide.

This is the fifth supplier award in the past eight years that Altera has received from Mindray, and the two companies have established a proven relationship of joint cooperation to drive for quality and to support customer success. Altera technology, including its Altera Cyclone® FPGAs are used by Mindray in its imaging and diagnostic products.

Altera Cyclone® FPGAs are built to meet systems designers' low power, cost-sensitive design needs, enabling faster time-to-market. Each generation of Cyclone FPGAs solves the technical challenges of increased integration, increased performance, lower power, while meeting cost-sensitive requirements.

"We are happy to present Altera with the Best Quality Award," said Jing Jungang, general manager of the manufacturing center at Mindray. "Altera's professional team has worked closely with us to ensure our delivery of high-quality medical products to end customers, and this award is very well-deserved."

"We are honored to receive this prestigious award from Mindray recognizing Altera's contribution to its great success in the global medical devices market in 2013," said Erhaan Shaikh, regional vice president and managing director of Altera Asia Pacific. "We strive to provide our customers with innovative, high-quality products, combined with outstanding service, enabling them to deliver superior value to their end markets. We appreciate the long and successful partnership between Altera and Mindray and look forward to many years of mutual success."

About Altera

Altera® programmable solutions enable designers of electronic systems to rapidly and cost effectively innovate, differentiate and win in their markets. Altera offers FPGAs, SoCs, CPLDs, ASICs and complementary technologies, such as power management, to provide high-value solutions to customers worldwide. Visit www.Altera.com.

ALTERA, ARRIA, CYCLONE, ENPIRION, MAX, MEGACORE, NIOS, QUARTUS and STRATIX words and logos are trademarks of Altera Corporation and registered in the U.S. Patent and Trademark Office and in other countries. All other words and logos identified as trademarks or service marks are the property of their respective holders as described at www.altera.com/legal

Editor Contact:
Karin Taylor
Altera Corporation
(408) 544-8207
newsroom@altera.com

Logo - http://photos.prnewswire.com/prnh/20101012/SF78952LOGO

SOURCE Altera Corporation

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.